Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 90,391

Document Document Title
WO/2016/106343A8
Aspects of the present disclosure relate to genetically engineered organisms useful for the diagnosis and treatment of inflammatory bowel disease.  
WO/2016/105479A1
Herein is provided a method that provides a patient, suspected of having Lyme disease, a kit that does not require specialized equipment and allows for easy self-collection of specimens. Methods provided herein, allow for the efficient c...  
WO/2016/103217A1
The present invention relates to an in vitro method of culturing a segmented filamentous bacterium strain, comprising co-culturing said segmented filamentous bacterium strain with a eukaryotic host cell, wherein the culture is performed ...  
WO/2016/104424A1
Provided are cyanobacteria having improved fatty acid productivity. A method for producing modified cyanobacteria, the method including knockout of LexA-type transcription regulator and acyl-ACP synthetase in cyanobacteria.  
WO/2016/105483A1
Methods for increasing the genetic stability of genetically enhanced microbial host capable of producing a compound of interest are disclosed.  
WO/2016/104607A1
The purpose of the present invention is to provide a ω3 desaturase that has high enzymatic activity even at normal temperatures. Specifically provided are: a polypeptide which is composed of an amino acid sequence having at least 80% se...  
WO/2016/106283A1
Embodiments of the disclosure include systems and methods for capturing particular biological matter from a sample from an individual. The systems and methods employ an apparatus (such as a container that is a tube or bag) comprising a f...  
WO/2016/106239A1
The disclosure provides methods and compositions for the integration (insertion) of a donor DNA molecule into a target DNA molecule. In general, the methods include contacting a target DNA molecule with a linear donor DNA molecule and a ...  
WO/2016/103699A1
The present invention enhances the organic-acid-production efficiency of bifidobacteria and lactic acid bacteria regardless of the numbers of these beneficial bacteria. The problem is overcome by an organic-acid-production promoter for p...  
WO/2016/102853A1
The invention relates to an isolated strain of the Lactobacillus genus, characterised by its capacity to grow in the germination medium of a seed, and to limit the growth of bacteria such as Enterobactericaceae, more specifically E. coli...  
WO/2016/101960A3
The invention relates to yeast cells with useful characteristics, including being capable of utilizing panose as sole carbon source and/or capable of utilizing one or more dipeptidesas sole nitrogen source. The invention also relates to ...  
WO/2016/105510A3
The present invention relates to the field of bacteriology. In particular, the invention relates to methods and compositions for treatment and prevention of infection in wounds, and methods for producing and storing bacterial donor organ...  
WO/2016/104814A3
A method for producing a dicarboxylic acid is provided. A dicarboxylic acid is produced by culturing a bacterium having a dicarboxylic acid-producing ability, which has been modified so that the expression of one or more genes selected f...  
WO/2016/105405A1
Methods for making marker-free genetically enhanced microbial host cells capable of producing a compound of interest are disclosed. Also disclosed are plasmids comprising the genes required to produce the compound of interest in the host...  
WO/2016/105510A2
The present invention relates to the field of bacteriology. In particular, the invention relates to methods and compositions for treatment and prevention of infection in wounds, and methods for producing and storing bacterial donor organ...  
WO/2016/104814A2
A method for producing a dicarboxylic acid is provided. A dicarboxylic acid is produced by culturing a bacterium having a dicarboxylic acid-producing ability, which has been modified so that the expression of one or more genes selected f...  
WO/2016/103005A1
The present invention relates to an in vitro method of culturing a segmented filamentous bacterium strain, comprising co-culturing said segmented filamentous bacterium strain with a eukaryotic host cell, wherein the culture is performed ...  
WO/2016/106343A1
Aspects of the present disclosure relate to genetically engineered organisms useful for the diagnosis and treatment of inflammatory bowel disease.  
WO/2016/104666A1
The purpose of the present invention is to provide a liquid transport method for efficiently producing cell cultures. This liquid transport method is used during cell processing and has: a) a step in which a container holding a liquid is...  
WO/2016/099073A1
The present invention relates to a method for inducing the growth of and culturing granule microbial communities for hydrogen production, and has an effect of enabling the stable production of hydrogen without losing microbes even with a...  
WO/2016/097857A1
This invention relates to methods of treatment of a sewage transport system, including reducing odour, reducing hydrogen sulfide production, reducing and/or preventing corrosion, reducing and/or preventing biofilm formation and/or adhesi...  
WO/2016/095326A1
Provided is a construction method for OCH1-defective anti-CD20 tetravalent antibody expression Pichia pastoris, comprising: knocking out an OCH1 encoded α-1, 6-mannosyltransferase of a strain JC308; connecting the modified och1 with no ...  
WO/2016/096821A1
The present invention relates to a method for prolonging spore viability of fungal spores present in a liquid formulation, comprising (a) packaging said formulation in a suitable container; (b) reducing oxygen exposure of the spores in s...  
WO/2016/098356A1
An objective of the invention is to provide anti-C5 antibodies and methods of using the same. The invention provides anti-C5 antibodies and methods of using the same. In some embodiments, an isolated anti-C5 antibody of the present inven...  
WO/2016/098838A1
 This peptide has an NFκB inhibitory effect and is any one of the following peptides: (a) a peptide comprising any amino acid sequence from SEQ ID NOs: 1-5; (b) a peptide having an NFκB inhibitory effect and comprising any amino acid...  
WO/2016/098711A1
The purpose of the present invention is to provide a fundamental solution for eliminating eutrophication of lakes, etc., purifying riverine systems in which the water quality is degraded due to proliferation of microalgae such as blue-gr...  
WO/2016/095223A1
A double-carbonyl reductase mutant and application thereof. An amino acid sequence of the double-carbonyl reductase mutant is the mutant amino acid sequence coded by SEQ ID NO:9, the mutant amino acid sequence has at least two mutation s...  
WO/2016/100929A1
Disclosed herein are compositions comprising use of compositions comprising a live attenuated recombinant Listeria strain comprising a fusion protein of a truncated listeriolysin O (LLO) protein, a truncated ActA protein, or a PEST amino...  
WO/2016/099401A1
The present invention relates to the field of fungal biotechnology, more particularly to genetic engineering methods for the production of carotenoids in fungal hosts selected from Rhodospordium and Rhodotorula genera.  
WO/2016/099917A1
The present invention relates in general to bacterial cells having genetic alterations that result in increased expression of a protein of interest and methods of making and using such cells. Aspects of the present invention include alte...  
WO/2016/098357A1
The disclosure provides anti-myostatin antibodies and methods of making and using the same. Nucleic acids encoding the anti-myostatin antibodies and host cells comprising the nucleic acids are also provided. The disclosure also provides ...  
WO/2016/100881A1
A bacterial composition that inhibits E. coli O157:H7 growth by as much as 93% and Salmonella growth by as much as 97%, together with commensurate inhibition rates against the Big-Six Escherichia coli strains referred to as the non-O157 ...  
WO/2016/090472A1
The present invention relates to novel polypeptides and enzymes (e.g., thermostable proteins and enzymes) having activities relating to biomass processing and/or degradation (e.g., cell wall deconstruction), as well as polynucleotides, v...  
WO/2016/092201A1
The invention relates to a method for preserving microorganisms at ambient temperature, wherein: - a composition, referred to as the preservative composition, is prepared, said composition comprising the microorganisms to be preserved an...  
WO/2016/093450A1
The present invention relates to L. plantarum-K-1 BR (LP), which is lactobacillus that is separated from Kimchi and identified, the L. plantarum-K-1 BR (LP) exhibiting an anti-allergic effect; being capable of improved treatment of disea...  
WO/2016/090431A1
The present specification relates to an antimicrobial agent, comprising a microbial cell of the genus Mesorhizobium or an extracellular polymeric substance (EPS) or polysaccharide component of the EPS, produced by said cell, various uses...  
WO/2016/090622A1
Provided are a hydroxyacyl-coenzyme A dehydrogenase gene and an acyl-coenzyme A thiolase gene, and a genetically-engineered bacteria and a use thereof. The hydroxyacyl-coenzyme A dehydrogenase gene encodes a protein (i) or (ii) as follow...  
WO/2016/092787A1
Isolated GPC3-derived epitope peptides having Th1 cell inducibility are disclosed herein. Such peptides can be recognized by MHC class II molecules and induce Th1 cells. In preferred embodiments, such a peptide of the present invention c...  
WO/2016/094520A1
Disclosed are transformed cells comprising one or more genetic modifications that affect the lipid content of the cell, e.g., by increasing the concentration of oleic acid in the cell relative to an unmodified cell of the same type. Also...  
WO/2016/090618A1
Provided are a biological metal corrosion inhibitor and a use thereof. The biological metal corrosion inhibitor contains Vibrio neocaledonicus sp., which can form a biological film with a metal corrosion inhibition effect on the surface ...  
WO/2016/091980A1
The present invention relates to a method for degrading DNA in a sample obtained by microbial fermentation or biotransformation, comprising treating the sample with a combination of increased temperature and low pH. It also relates to a ...  
WO/2016/090432A1
The present specification relates to a composite filtration membrane, various uses thereof and its method of production. The composite filtration membrane comprising a layer comprising an extracellular polymeric substance (EPS) produced ...  
WO/2016/090474A1
The present invention relates to novel polypeptides and enzymes (e.g., thermostable proteins and enzymes) having activities relating to biomass processing and/or degradation (e.g., cell wall deconstruction), as well as polynucleotides, v...  
WO/2016/092990A1
A process (S1) for producing freeze-dried sludge comprising: an acclimatization step (S10) in which a load is imposed on cells of a microorganism present in activated sludge to acclimatize the cells; a production increase step (S21) in w...  
WO/2016/090473A1
The present invention relates to novel polypeptides and enzymes (e.g., thermostable proteins and enzymes) having activities relating to biomass processing and/or degradation (e.g., cell wall deconstruction), as well as polynucleotides, v...  
WO/2016/090440A1
The development of attenuated live vaccines against salmonellosis has increased over the past years due to the nonexistence of completely effective vaccine formulations which enable different S. enterica serovars to be more effectively c...  
WO/2016/090479A1
Disclosed is a method for tracing marine species movement and location by using ratios of stable Iron isotopes. Marine phytoplankton consumes Iron as part of their photosynthetic process. If unique Iron isotope formulations are delivered...  
WO/2016/092828A1
This method for the rupture of algae involves physical treatment using a high-pressure dispersing device after subjecting microalgae belonging to Heterokontophyta to heat treatment at a temperature of 40-65°C at a pH of 3.5-9.5.  
WO/2016/090556A1
Provided are a fungus-sourced high-temperature neutral Family-45 cellulase as well as a coding gene and an application thereof. The cellulase has the optimal pH value of 5.5 and the optimal temperature of 60°C, has certain enzyme activi...  
WO/2016/088824A1
The present invention addresses the problem of providing a vector having improved stability in a host cell. The present invention provides a vector which is stably held in a host cell, wherein the vector contains a base sequence represen...  

Matches 151 - 200 out of 90,391